2022 annual financial data
Forte Biosciences, Inc. 2022 Operating margin
Forte Biosciences, Inc. 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -13,896,000 USD and net income was -13,862,000 USD.
Operating cash flow was -8,185,000 USD.
Get free Forte Biosciences, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -13,896,000 USD
- Net income
- -13,862,000 USD
- Operating cash flow
- -8,185,000 USD